BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4885372)

  • 1. [Effect of chloramphenicol against different E. coli strains in vitro and in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Sep; 18(9):1123-7. PubMed ID: 4885372
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the bacterilogy and serology of experimental pyelonephritis under the action of chloramphenicol].
    Ritzerfeld W; Prát V; Konícková L; Losse H
    Arch Hyg Bakteriol; 1967 Oct; 151(5):529-37. PubMed ID: 4882586
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on chloramphenicol sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prat V; Konickova L; Losse H
    Arch Hyg Bakteriol; 1968 Apr; 152(2):181-6. PubMed ID: 4884481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of chloramphenicol on experimental kidney infection caused by strains of E. coli with various sensitivity in vitro].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Cas Lek Cesk; 1969 Mar; 108(10):300-6. PubMed ID: 4887122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibacterial effect of two sulfonamide compoundds in acute experimental E. coli-pyelonephritis].
    Konicková L; Prát V; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1969 Oct; 19(10):1717-20. PubMed ID: 4902491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of antibacterial effect of rifampicin and cephaloridine on a model of E. coli pyelonephritis in rats].
    Prát V; Konícková L; Hatala M
    Arzneimittelforschung; 1970 Apr; 20(4):554-7. PubMed ID: 4911591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of infectious multiple resistance in pathogens causing pyelonephritis].
    Naumann G; Fanger K; Kunkel M
    Z Gesamte Inn Med; 1972 Jan; 27(1):18-21. PubMed ID: 4552533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sensitivity of an Escherichia coli strain to chloramphenicol during therapy of experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prát V; Konícková L; Losse H
    Cas Lek Cesk; 1969 Sep; 108(39):1156-60. PubMed ID: 4897608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arztl Forsch; 1968 Feb; 22(2):69-72. PubMed ID: 4876157
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prát V; Konicková L
    Arch Hyg Bakteriol; 1969 Jun; 153(3):254-9. PubMed ID: 4908403
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005].
    Soussy CJ; Lascols C; Dib-Smahi C;
    Med Mal Infect; 2007 Nov; 37(11):773-5. PubMed ID: 17936533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antibiotic effect of gentamycin in experimental acute Escherichia coli pyelonephritis].
    Ritzerfeld W; Prat V; Konickova L; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):254-8. PubMed ID: 4880994
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibacterial effect of nitrofurantoin in acute, ascending E. coli pyelonephritis of rats].
    Konícková L; Prát V; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Jun; 18(6):720-2. PubMed ID: 4885094
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methodical contribution to the evaluation of antibacterial efficacy of some chemotherapeutic agents in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):20-5. PubMed ID: 4896483
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriologic, histologic and functional studies of the kidney in 5 days' therapy of experimental E. coli pyelonephritis with gentamycin. Comparison with 9 days' therapy].
    Hagemann I; Briedigkeit H; Strangfeld D; Ditscherlein G; Schürer M; Pietsch R; Kruse I; Camu A; Blank W
    Z Urol Nephrol; 1985 Nov; 78(11):625-31. PubMed ID: 3913218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the resistance against trimethoprim-sulfonamide increasing?].
    Bollgren I; Fogström B; Myrbäck CE
    Lakartidningen; 1991 Jan; 88(4):212. PubMed ID: 1994159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies on the etiology and pathogenesis of pyelonephritis].
    Mohr HJ
    Beitr Pathol Anat; 1969; 138(4):357-76. PubMed ID: 4239799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
    Rudzit EA; Lisitsa LI
    Farmakol Toksikol; 1971; 34(2):246-50. PubMed ID: 4998195
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of antibacterial effect of ampicillin on ascending E. coli pyelonephritis in rats].
    Konícková L; Prát V; Hatala M
    Cesk Farm; 1969 Jun; 18(4):206-8. PubMed ID: 4895577
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological defense and virulence of the agent in experimental chronic infection].
    Henkel W; Freiesleben H; Wöhrmann W; Krüger C; Commichau R
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):306-13. PubMed ID: 4154602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.